Revisto
Revisto is an AI-powered platform that streamlines the medical, legal, and regulatory (MLR) review process for pharmaceutical marketing materials. It uses AI and proprietary pharmaceutical data to reduce the time and cost of MLR reviews, allowing life sciences companies to bring products to market faster while ensuring compliance. The platform integrates with existing workflows and CMS software.
Funding Round: Seed
Funding Amount: $4M
Date: 18-Nov-2024
Investors: LiveOak Ventures, Eli Lilly and Company, Tau Ventures, Arkin Digital Health
Markets: Pharmaceutical, AI, Healthtech, Life Sciences, Marketing
HQ: San Antonio, Texas, United States
Founded: 2023
Website: https://www.revisto.com/
LinkedIn: https://www.linkedin.com/company/revisto-inc/
Crunchbase: https://www.crunchbase.com/organization/revisto
Leave a Comment
Comments
No comments yet.